Diagnósticos da América S.A (DASA3.SA) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Services · Brazil · ISIN BRDASAACNOR1

Price
2.95 BRL
Market cap
3.70 bn BRL
P/E (2025)
–
P/S (2025)
0.33
Dividend yield
0.00 %
Net margin
-10.31 %
Return on equity (ROE)
-16.78 %
Return on assets (ROA)
-6.21 %

Diagnósticos da América S.A financials

Fiscal year20242025
Revenue15.32 bn BRL11.17 bn BRL
Gross profit4.19 bn BRL3.39 bn BRL
Operating income1.01 bn BRL1.01 bn BRL
EBIT784.32 m BRL915.24 m BRL
Net income-1.20 bn BRL-1.15 bn BRL
Diluted EPS – continuing operations-0.96 BRL-0.92 BRL

Full history since 2000, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Diagnósticos da América S.A

Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in São Paulo, Brazil.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.